Cellogen Therapeutics
Type
startup
Founded
2021
Funding captured
$4.1m
Deals captured
2
About Cellogen Therapeutics
Cellogen Therapeutics is a Hyderabad-based cellular engineering and gene-therapy company developing next-generation CAR-T and gene therapies for cancers and blood disorders. The company focuses on bispecific, dual-antigen CAR-T platforms and early-stage programmes for conditions such as beta thalassemia and sickle cell disease, with an emphasis on advancing clinical development, process development and GMP-compliant manufacturing capabilities.
Cellogen Therapeutics funding captured (2)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Equity | Unspecified | May 18, 2026 | $2.1m |  Kotak Alternate Assets Managers |
| **************** | **************** | **************** | $2.0m | **************** |